how many people are using glp-1 Survey: 37.5% of Stop GLP-1s after Just 3 Months Many people use GLP-1s to

Protein requirements: aiming for 1.2 to 2.0 grams of protein per kilogram of body weight helps repair tissues

indicating fewer symptoms) was significantly greater in the dapagliflozin group compared with the placebo group

5-year RR 1.40), but the time to event analysis did not demonstrate a statistically significant association

Nirmatrelvir and the risk of post-acute sequelae of COVID-19

Most patients notice appetite suppression within 3 days of their first dose, with significant weight loss results appearing within 4 to 12 weeks

The authors suggest that healthcare providers consider this increased risk when prescribing Ozempic, Rybelsus, and Wegovy and discuss it with patients as part of a comprehensive benefit-risk assessment